Dear Editor:
I wish to compliment Sredni et al. [1] for their report BSpontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system.^They found that incompletely resected pediatric low-grade gliomas which remained stable or involuted spontaneously expressed higher levels of the cannabinoid receptor 1 (CNR1) than those tumors which progressed. They suggested that spontaneous involution of these pediatric low-grade gliomas may have been induced by endocannabinoids. I found this particularly interesting in the light of our previous report of two incompletely resected septum pellucidum pediatric low-grade astrocytomas that involuted spontaneously concurrent with the use of cannabis [2] . I wonder if one might be able to identify a population of low-grade gliomas and perhaps other brain tumors with elevated levels of CNR1 that might be particularly susceptible to involution with the use of cannabis. This
Bdrug^could then be potentially used as a chemotherapeutic agent in such patients.
